These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 5068258)

  • 1. Study of the concentration of mucoprotein in the gastric juice from healthy subjects and gastroduodenal patients before and after treatment with a gastro-protective drug, zolimidine.
    Camarri E; Zaccherotti L; D'Alonzo D
    Arzneimittelforschung; 1972 Apr; 22(4):768-72. PubMed ID: 5068258
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of zolimidine, a derivative of imidazo (1,2-a) pyridine, on the gastric mucosa of patients with gastric disorders.
    Celli L; Clementi F; Santagostino C
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):105-23. PubMed ID: 809228
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of 'cytoprotective' drugs (carbenoxolone, zolimidine, prostanoic acid) on mucus secretion in patients with gastric ulcer.
    Parodi MC; Molinari F; Barocci S
    Scand J Gastroenterol Suppl; 1984; 92():163-6. PubMed ID: 6234649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of a new drug in the treatment of gastroduodenal diseases].
    Bagliani A; Borri P
    Minerva Gastroenterol; 1972; 18(3):165-74. PubMed ID: 4614114
    [No Abstract]   [Full Text] [Related]  

  • 5. [Composition of the gastric mucus of normal rats with stress ulcers treated with 2-(p-methylsulfonylphenyl-)- imidazo (1,2-a)- pyridine].
    Pallavicini G; Cetta G; Calatroni
    Boll Soc Ital Biol Sper; 1971 Oct; 47(20):644-7. PubMed ID: 5143113
    [No Abstract]   [Full Text] [Related]  

  • 6. [Functional and morphological changes of the stomach in evolutive phases of gastric ulcer].
    Fodor O; Cosma V; Popescu S; Ban A; Ciofu G; Tragor S; Ilea V; Grigoraş D; Cotul S; Erdösi S
    Stud Cercet Med Interna; 1968; 9(4):319-29. PubMed ID: 5679036
    [No Abstract]   [Full Text] [Related]  

  • 7. [Zolimidine. Evaluation of the symptomatic effect in patients with gastroduodenal diseases].
    Rizzi B; Giacomini F; Bandini V
    Minerva Gastroenterol; 1975; 21(4):258-65. PubMed ID: 778658
    [No Abstract]   [Full Text] [Related]  

  • 8. Proteins and sialic acid in the gastric juice of humans.
    Mejbaum-Katzenellenbogen ; Kuczyńska-Sekieta K; Skrzypczyk J
    Pol Med J; 1968; 7(1):43-7. PubMed ID: 5650201
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of the total proteins of the gastric juice by Lowry's method in normal subjects and in various gastropathies].
    Rodrigo Gómez JM; Aparisi Quereda L; Blanes Masson F; Serra Desfilis MA; Guix García J; Tomas Ridocci M; Parrilla Paricio P
    Rev Esp Enferm Apar Dig; 1973 Apr; 40(1):1-16. PubMed ID: 4705849
    [No Abstract]   [Full Text] [Related]  

  • 10. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gepharnate in the treatment of gastroduodenal ulcer].
    Meeroff M
    Minerva Gastroenterol; 1972; 18(1):51-6. PubMed ID: 4614111
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of pirenzepine in peptic ulcer and in non ulcerous gastroduodenal diseases. A multicentre controlled clinical trial.
    Giorgi-Conciato M; Daniotti S; Ferrari PA; Gaetani M; Petrin G; Sala P; Valentini P
    Scand J Gastroenterol Suppl; 1982; 81():1-41. PubMed ID: 6221398
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serotonin metabolism in peptic ulcer].
    Geller LI; Kozlova ZP; Kontsevaia NG
    Zentralbl Gynakol; 1969 Dec; 91(50):22-7. PubMed ID: 5382055
    [No Abstract]   [Full Text] [Related]  

  • 14. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
    Nakao K; Imoto I; Ikemura N; Shibata T; Takaji S; Taguchi Y; Misaki M; Yamauchi K; Yamazaki N
    Am J Gastroenterol; 1997 Jun; 92(6):1005-11. PubMed ID: 9177520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the diagnostic value of testing gastromucoproteins in duodenal ulcer and chronic gastritis].
    Asauliuk IK; Krinitskiĭ AF; Korshunova EP
    Vrach Delo; 1969 Jun; 6():48-50. PubMed ID: 4898168
    [No Abstract]   [Full Text] [Related]  

  • 16. [Proglumide (milide) in gastroduodenal therapeutics].
    Geoffroy H; el-Haddad A; Coudoux P
    Sem Hop Ther; 1974 Mar; 50(3):207-16. PubMed ID: 4612709
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sucralfate: the agent of choice in the treatment of peptic ulcer?].
    Fedorov NE; Laktionova AA; Tkachev AV; Iakovlev AA; Soboleva LV; Grib VM
    Ter Arkh; 1990; 62(2):64-7. PubMed ID: 2186496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophil infiltration, gastric juice and serum eosinophil cationic protein levels in Helicobacter pylori-associated chronic gastritis and gastric ulcer.
    Aydemir SA; Tekin IO; Numanoglu G; Borazan A; Ustundag Y
    Mediators Inflamm; 2004 Dec; 13(5-6):369-72. PubMed ID: 15770055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of eradication therapy on nitrogen oxide activity in the gastric juice of patients with chronic gastritis and ulcer disease].
    Esedov EM; Magomedéminova AS
    Klin Med (Mosk); 2009; 87(7):50-2. PubMed ID: 19705793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of adrenergic substances on the acid and alkaline secretion of the stomach].
    Anshelevich YuV ; Okun KV
    Ter Arkh; 1972 Oct; 44(10):47-9. PubMed ID: 4144669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.